The Ministry of Health, Labor and Welfare has decided to enter into an on-site investigation on the 24th for "Nichi-Iko", a major generic drug company that has received an order to suspend operations from Toyama Prefecture for manufacturing drugs in a process not approved by the government. I did.
It is extremely unusual for the national government to undertake an on-site investigation while orders to suspend operations by local governments continue, and it seems that the aim is to thoroughly confirm whether quality control is being carried out properly.
At Nichi-Iko's Toyama Daiichi Plant in Namerikawa City, Toyama Prefecture, it was discovered that generic drugs had been manufactured in a process not approved by the government for more than 10 years, and this month Toyama Prefecture issued an order to suspend operations. We put it out and took measures such as suspending the sale of products company-wide for 24 days.
Based on the Pharmaceuticals and Medical Devices Act on the 24th, jointly with Toyama Prefecture and PMDA = Pharmaceuticals and Medical Devices Agency, where the Ministry of Health, Labor and Welfare examines pharmaceuticals, before the disposal is completed from the 29th of this month. Interviews with related parties revealed that we have decided to enter into an on-site inspection.
It is extremely unusual for the national government to undertake an on-site investigation while orders to suspend operations by prefectures continue, and it seems that the aim is to thoroughly confirm that quality control is being carried out properly before resuming operations.
In the industry, Kobayashi Kako Co., Ltd. in Fukui Prefecture, which mixed the ingredients of sleep-inducing agents into therapeutic agents, just issued an order to suspend operations for 116 days, the longest ever, and the current situation is that trust in generic drugs is shaking. We can see the strong sense of crisis of the country against.